{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:08Z","timestamp":1786993628163,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jvs.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:12:39Z","timestamp":1694949159000},"page":"111-119.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic immunosuppression does not affect revascularization outcomes in patients with chronic limb-threatening ischemia"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6359-6927","authenticated-orcid":false,"given":"Daniel J.","family":"Romary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha P.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-2573","authenticated-orcid":false,"given":"Marc L.","family":"Schermerhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2023.09.015_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMcp1709326","article-title":"Chronic limb-threatening ischemia","volume":"379","author":"Farber","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.09.015_bib2","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic Review and meta-analysis of randomized controlled trials. Review","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.09.015_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.avsg.2018.07.038","article-title":"Outcomes after lower extremity revascularization for treatment of critical limb ischemia with tissue loss in patients with chronic immune-mediated inflammatory disease","volume":"55","author":"O'Brien-Irr","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0741-5214(03)00074-0","article-title":"Clinical relevance of peripheral vascular occlusive disease in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"38","author":"Henke","year":"2003","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.avsg.2010.07.015","article-title":"The effect of immunosuppression on lower extremity arterial bypass outcomes","volume":"25","author":"Grisafi","year":"2011","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5414\/CN108956","article-title":"Effect of systemic immunosuppressive drugs on the patency of hemodialysis accesses","volume":"89","author":"Lee","year":"2018","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jvs.2023.09.015_bib7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jvs.2020.07.091","article-title":"Wound location is independently associated with adverse outcomes following first-time revascularization for tissue loss","volume":"73","author":"Darling","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib10","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic inter-society consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0741-5214(97)70144-7","article-title":"Immunosuppression for human saphenous vein allograft bypass surgery: a prospective randomized trial","volume":"26","author":"Carpenter","year":"1997","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.avsg.2021.07.010","article-title":"Cohort study examining the association of immunosuppressant drug prescription with major adverse cardiovascular and limb events in patients with peripheral artery disease","volume":"78","author":"Golledge","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2023.09.015_bib13","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1161\/01.CIR.0000033973.06059.04","article-title":"Oral everolimus inhibits in-stent neointimal growth","volume":"106","author":"Farb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.09.015_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/rheumatology\/kei245","article-title":"Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu's arteritis","volume":"45","author":"Park","year":"2006","journal-title":"Rheumatology"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423019821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423019821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:41:05Z","timestamp":1760042465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521423019821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0741521423019821"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2023.09.015","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic immunosuppression does not affect revascularization outcomes in patients with chronic limb-threatening ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}